Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population

被引:4
|
作者
Sidhwani, Santosh Kumar [1 ]
Mirza, Talat [2 ,3 ]
Khatoon, Ambrina [3 ]
Shaikh, Fouzia [1 ]
Khan, Rizma [4 ]
Shaikh, Omer Ahmed [5 ]
Nashwan, Abdulqadir J. [6 ]
机构
[1] Ziauddin Univ, Dept Pathol, Karachi, Pakistan
[2] Ziauddin Univ, Dept Res, Karachi, Pakistan
[3] Ziauddin Univ, Dept Mol Med, Karachi, Pakistan
[4] Ziauddin Univ, Dept Mol Genet, Karachi, Pakistan
[5] Ziauddin Univ, Dept Med, Karachi, Pakistan
[6] Nursing Educ Hamad Med Corp, POB 3050, Doha, Qatar
关键词
SARS-CoV-2; ACE2; Polymorphisms; rs2285666; Variants; SNPs; HYPERTENSION;
D O I
10.1186/s12985-023-02091-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Science is digging for the varied presentation of COVID-19 patients exposed to the same risk factors, and medical conditions may be influenced by the presence of polymorphic genetic variants. This study investigated the link between ACE2 gene polymorphisms and the severity of SARS-CoV-2. This cross-sectional study recruited COVID-19 PCR-positive patients by consecutive sampling from Ziauddin Hospital from April to September 2020. DNA was extracted from whole blood, followed by gene amplification and Sanger's sequencing. Most of the patients, 77: 53.8%, were serious. Males were higher (80; 55.9%) with age more than 50 years (106: 74.1%). We found 22 ACE2 SNPs. rs2285666 SNP was most prevalent with 49.2% CC, 45.2% TT, 4.8% CT heterozygosity, and 0.8% AA genotypes. Variants with multiple genotypes were also insignificantly associated with the severity of COVID-19 in the analysis of the dominant model. Only rs2285666 had a significant statistical link with gender (p-value 0.034, OR; 1.438, CI; 1.028-2.011) while rs768883316 with age groups (p-value 0.026, OR; 1.953, CI; 1.085-3.514). Haplotypes ATC of three polymorphisms (rs560997634, rs201159862, and rs751170930) commonly found in 120 (69.77%) and TTTGTAGTTAGTA haplotype consisting of 13 polymorphisms (rs756737634, rs146991645, rs1601703288, rs1927830489, rs1927831624, rs764947941, rs752242172, rs73195521, rs781378335, rs756597390, rs780478736, rs148006212, rs768583671) in 112 (90.32%) had statistically significant association with the severity having p = value 0.029 and 0.001 respectively. Males of old age and diabetics are found to have more severe COVID-19 infection in the current study. We also found that common ACE2 polymorphism rs2285666 influences the susceptibility of acquiring the severe SARS-CoV-2 infection.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] ACE2: the molecular doorway to SARS-CoV-2
    Medina-Enriquez, Miriam Marlene
    Lopez-Leon, Sandra
    Carlos-Escalante, Jose Alberto
    Aponte-Torres, Zuleika
    Cuapio, Angelica
    Wegman-Ostrosky, Talia
    CELL AND BIOSCIENCE, 2020, 10 (01)
  • [22] Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses
    Samad, Abdus
    Jafar, Tamanna
    Rafi, Jahirul Hasnat
    GENOMICS, 2020, 112 (06) : 4912 - 4923
  • [23] Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2
    Hallaj, Shahin
    Ghorbani, Anahita
    Mousavi-Aghdas, Seyed Ali
    Mirza-Aghazadeh-Attari, Mohammad
    Sevbitov, Andrey
    Hashemi, Vida
    Hallaj, Tooba
    Jadidi-Niaragh, Farhad
    IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (02) : 192 - 205
  • [24] Gastrointestinal and kidney manifestations in SARS-CoV and SARS-CoV-2 infections: role of angiotensin-converting enzyme 2
    Maghool, Fatemeh
    Emami, Mohammad Hassan
    Mohammadzadeh, Samaneh
    Heidari, Aida
    Safari, Tahereh
    PHYSIOLOGY AND PHARMACOLOGY, 2021, 25 (01): : 7 - 20
  • [25] SARS-CoV-2 Susceptibility and ACE2 Gene Variations Within Diverse Ethnic Backgrounds
    Vadgama, Nirmal
    Kreymerman, Alexander
    Campbell, Jackie
    Shamardina, Olga
    Brugger, Christiane
    Consortium, Genomics England Research
    Deaconescu, Alexandra M.
    Lee, Richard T.
    Penkett, Christopher J.
    Gifford, Casey A.
    Mercola, Mark
    Nasir, Jamal
    Karakikes, Ioannis
    FRONTIERS IN GENETICS, 2022, 13
  • [26] Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa
    Takabayashi, Tetsuji
    Yoshida, Kanako
    Imoto, Yoshimasa
    Schleimer, Robert P.
    Fujieda, Shigeharu
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2022, 36 (01) : 115 - 122
  • [27] Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
    Vargas-Rodriguez, Jose R.
    Garza-Veloz, Idalia
    Flores-Morales, Virginia
    Badillo-Almaraz, Jose I.
    Rocha-Pizana, Maria R.
    Valdes-Aguayo, Jose J.
    Martinez-Fierro, Margarita L.
    FRONTIERS IN MEDICINE, 2022, 8
  • [28] Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection
    Paul, Deepraj
    Mohankumar, Suresh K.
    Thomas, Rhian S.
    Kheng, Chai B.
    Basavan, Duraiswamy
    CURRENT DRUG TARGETS, 2022, 23 (04) : 364 - 372
  • [29] Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)
    To, KF
    Lo, AW
    JOURNAL OF PATHOLOGY, 2004, 203 (03) : 740 - 743
  • [30] Angiotensin-Converting Enzyme 2 (SARS-CoV-2 receptor) expression in human skeletal muscle
    Perez-Valera, Mario
    Martinez-Canton, Miriam
    Gallego-Selles, Angel
    Galvan-Alvarez, Victor
    Gelabert-Rebato, Miriam
    Morales-Alamo, David
    Santana, Alfredo
    Martin-Rodriguez, Saul
    Ponce-Gonzalez, Jesus Gustavo
    Larsen, Steen
    Losa-Reyna, Jose
    Perez-Suarez, Ismael
    Dorado, Cecilia
    Curtelin, David
    Gonzalez-Henriquez, Juan Jose
    Boushel, Robert
    Hallen, Jostein
    de Pablos Velasco, Pedro
    Freixinet-Gilart, Jorge
    Holmberg, Hans-Christer
    Helge, Jorn W.
    Martin-Rincon, Marcos
    Calbet, Jose A. L.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2021, 31 (12) : 2249 - 2258